Latest Biospecifics Technologies Corp (BSTC)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Biospecifics Technologies Corp (BSTC) Headlines

OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 6.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:51AM CST
OncoGenex Pharmaceuticals, Inc. was a big mover last session, as its shares rose nearly 7% on the day.

BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2013 Financial Results
PR Newswire - Thu Mar 06, 7:00AM CST
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial results for the fourth quarter and full year ended December 31, 2013 and provided a corporate update.

Auxilium Pharma Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 10:00AM CST
Revenues were boosted by the recently acquired subsidiary, Actient, as well as higher Xiaflex sales in the U.S.

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (strong buy) List for Monday

Alcobra (ADHD) Jumps: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 8:04AM CST
Alcobra Ltd. was a big mover last session, as the company saw its shares rise by over 8% on the day.

Durata Therapeutics (DRTX) Jumps: Stock Rises 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:21AM CST
Durata Therapeutics, Inc. (DRTX) was a big mover last session, as the company saw its shares rise by over 6% on the day.

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 14, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (strong buy) List for Friday

Positive Data on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 09, 11:10AM CST
BioSpecifics Technologies recently announced encouraging top-line data on Xiaflex from a phase II dose escalation clinical trial for the treatment of human lipoma.

Biotech Stock Roundup: Christmas Gift for UTHR, TSRO Tumbles - Analyst Blog
Arpita Dutt - Zacks Investment Research - Thu Jan 02, 9:48AM CST
Altogether it was a slow week for the biotech sector though companies like UTHR made the headlines.

Update on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 27, 3:20PM CST
BioSpecifics Technologies is working hard to develop its pipeline .

Pipeline Progress at Auxilium Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 16, 2:35PM CST
Auxilium Pharmaceuticals recently dosed its first patient for the phase II study on Xiaflex for the treatment of frozen shoulder syndrome (adhesive capsulitis).

Auxilium Up on Peyronie's Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 9:40AM CST
Xiaflex, currently marketed for Dupuytren's Contracture, gained FDA approval for Peyronie's disease.

Zacks #1 Rank Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 7:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Monday

BioSpecifics Technologies Corp. (BSTC) in Focus: Stock Moves 6.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 09, 7:21AM CST
BioSpecifics Technologies Corp. (BSTC) was a big mover last session, as the company saw its shares rise by roughly 7% on the day.

FDA approves first drug for rare erection disorder
AP - Fri Dec 06, 1:34PM CST
WASHINGTON (AP) — The Food and Drug Administration on Friday approved the first drug to treat an unusual condition that causes painful, curved erections in men.

Cadence Pharmaceuticals Inc. (CADX) Jumps: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 04, 7:32AM CST
Cadence Pharmaceuticals Inc. was a big mover last session, as the company saw its shares rise over 6% on the day.

Zacks #1 Rank Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 03, 7:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Tuesday

Data on Auxilium Pharma's Xiaflex - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 10:10AM CST
Auxilium Pharma announced encouraging results on Xiaflex from the MULTICORD (Multiple Treatment Investigation of Collagenase Optimizing the Resolution of Dupuytren's) study.

Regulatory Setback for Forest/Gedeon - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 9:30AM CST
Forest Labs and Gedeon Richter intend to meet with the FDA shortly to determine the path forward for cariprazine.

QLT (QLTI) Surges: Stock Moves 11.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 21, 6:37AM CST
QLT Inc. was a big mover last session, as the company saw its shares rise nearly 12% on the day.

BioSpecifics Technologies Corp. (BSTC) Stock Research Links

BSTC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 116

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 124

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Stellus Capital Set to Unveil Q3 Results: Key Details

Updated Category News Views 79

Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...

Continue Reading
ILC Dover Faces $13M Cybersecurity Fraud Penalty

Updated Category News Views 83

Big Bucks for Cyber Missteps When it rains, it pours—or in the case of ILC Dover, it’s a downpour of $13 million they’re forking over to settle a gnarly cybersecurity debacle. If you blinked, you might miss this hefty payout marking the biggest recovery under the Department of Justice’s Civil Cybersecurity Fraud program. So, what's the fuss about? Well, it's got...

Continue Reading
LONGi Achieves 10th BNEF Tier 1 Listing Amidst Stricter Rules

Updated Category News Views 93

LONGi Surpasses New BNEF Barriers with Ease Alright, let's dig into the meat of the matter today. LONGi has snagged its 10th straight spot in BloombergNEF's (BNEF) Tier 1 list of global energy storage manufacturers. And mind you, that's no small potatoes, especially with stricter financing demands rearing their hefty heads this quarter. Non-Recourse Financing: A Tougher...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 20

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading
LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

Updated Category News Views 51

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Continue Reading
CVS Health Boosts 2026 Guidance Amid Revenue Jump

Updated Category News Views 89

A Solid Quarter for CVS Health CVS Health Corporation has once again turned heads with its third-quarter 2026 results. When you're pulling $108.4 billion in quarterly revenue, up 5.4% from last year, folks notice. Adjusted earnings hit $2.09 per share, climbing a respectable 30% from $1.60 the year before. The cherry on top? A big fat boost in 2026 guidance, signaling...

Continue Reading
Parloa and Deloitte Canada Revamp Customer Experience

Updated Category News Views 37

Even in this digital age, customer service sometimes feels as outdated as a rotary phone. But along comes Parloa, sharpening its edge in North America by shaking hands with Deloitte Canada to overhaul the typical customer service experience. This isn't just another handshake; it's a full-fledged mission to rewire customer interactions through innovative AI-powered...

Continue Reading
A2Gold Tackles Tough Terrain at Eastside Project

Updated Category News Views 58

Drilling Challenges and Initial Observations Folks, it's a roller coaster out there—A2Gold just wrapped up a gritty round of drilling at their Eastside Gold-Silver Project near Tonopah, Nevada. They've punched through five reverse circulation (RC) holes, totaling 1,936 meters, all while battling tough conditions. You could say they've truly earned their stripes in the...

Continue Reading

Top 5 Most Recently Viewed Articles

CMIT Solutions Strengthens Service Capabilities with Velox Systems Acquisition

Updated Category News Views 558

CMIT Solutions Strengthens IT Services with Strategic Acquisition Nation's Leading IT Provider Enhances Corporate Portfolio with Automation and Cybersecurity Expertise In a significant move to enhance its service offerings, CMIT Solutions has recently acquired Velox Systems, a managed service provider renowned for its innovative solutions and expertise in advanced...

Continue Reading
NextEra Energy Prepares for 2025 Financial Results Announcement

Updated Category News Views 111

NextEra Energy to Reveal 2025 Financial Results NextEra Energy, Inc. (NYSE: NEE) has recently revealed its plans to disclose the fourth-quarter and full-year financial results for 2025. This announcement is set to take place before the opening of the New York Stock Exchange, specifically on Tuesday, January 27, 2026. Investors and interested parties can expect a news...

Continue Reading
Donaldson Company Achieves Record Sales and Earnings in Q1

Updated Category News Views 120

Donaldson Company Reports Progress in First Quarter Donaldson Company, Inc. (NYSE: DCI), recognized globally for its innovative filtration solutions, has released its financial results for the first quarter of fiscal year 2025. The company celebrated a remarkable achievement in both sales and earnings, revealing GAAP net earnings of $99 million, a rise from $92.1 million...

Continue Reading
Challenges and Risks of China's Imbalanced Economy Explained

Updated Category News Views 290

Understanding the Challenges of China's Economy Scott Bessent, an influential figure in U.S. economic policy, recently voiced significant concerns regarding the structure of China’s economy. He characterized it as one of the most unbalanced economies in contemporary history, a viewpoint that has formed the basis of discussions around global trade relations. China's...

Continue Reading
Acrivon Therapeutics Prepares for Key Clinical Updates in 2026

Updated Category News Views 156

Acrivon Therapeutics to Reveal Exciting Clinical Developments Acrivon Therapeutics, Inc. is on the verge of announcing significant updates regarding its clinical pipeline, specifically focusing on ACR-368 and ACR-2316. This Massachusetts-based biotechnology company leverages its unique Generative Phosphoproteomics AP3 platform to develop precision medicines aimed at...

Continue Reading